Where might the fixed ratio, combination regimens consisting of a long-acting insulin and GLP-1 RA fit into the ADA and AACE guidelines and how do your see their use in the sequencing algorithm for T2D?

Where might the fixed ratio, combination regimens consisting of a long-acting insulin and GLP-1 RA fit into the ADA and AACE guidelines and how do your see their use in the sequencing algorithm for T2D?

Where might the fixed ratio, combination regimens consisting of a long-acting insulin and GLP-1 RA fit into the ADA and AACE guidelines and how do your see their use in the sequencing algorithm for T2D?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Silvio Inzucchi, MD

Silvio Inzucchi, MD

Professor of Medicine (Endocrinology) Clinical Director, Section of Endocrinology Director, Yale Diabetes Center Director, Endocrinology & Metabolism Fellowship New Haven, Connecticut